Berlin-Frankfurt-Muenster protocol II

chemotherapy protocol consisting of above cpds for treatment of high-risk childhood acute lymphoblastic leukemia

Also Known As:

BFM protocol II

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - Berlin-Frankfurt-Muenster protocol II: 1
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - Berlin-Frankfurt-Muenster protocol II: 1
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - Berlin-Frankfurt-Muenster protocol II: 1
Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Amidohydrolases: 43
      - Asparaginase: 2285
        Berlin-Frankfurt-Muenster protocol II: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        Berlin-Frankfurt-Muenster protocol II: 1
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        Berlin-Frankfurt-Muenster protocol II: 1
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        Berlin-Frankfurt-Muenster protocol II: 1
Heterocyclic Compounds: 198
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        Berlin-Frankfurt-Muenster protocol II: 1
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - Berlin-Frankfurt-Muenster protocol II: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        Berlin-Frankfurt-Muenster protocol II: 1
- Fused-Ring Compounds
  - Steroids: 70059
    - Fluorinated Steroids: 32
      - Dexamethasone: 23151
        Berlin-Frankfurt-Muenster protocol II: 1
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Dexamethasone: 23151
        Berlin-Frankfurt-Muenster protocol II: 1
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        Berlin-Frankfurt-Muenster protocol II: 1

Experts

1.	Aricò, Maurizio: 1 article (07/2002)
2.	Barisone, Elena: 1 article (07/2002)
3.	Basso, Giuseppe: 1 article (07/2002)
4.	Conter, Valentino: 1 article (07/2002)
5.	De Rossi, Giulio: 1 article (07/2002)
6.	Locatelli, Franco: 1 article (07/2002)
7.	Masera, Giuseppe: 1 article (07/2002)
8.	Messina, Chiara: 1 article (07/2002)
9.	Micalizzi, Maria Concetta: 1 article (07/2002)
10.	Pession, Andrea: 1 article (07/2002)

Related Diseases

1.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/15/2002 - "Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II."

Related Drugs and Biologics

1.	Prednisone (Sone)